Immunohistochemical expression of E-cadherin and β-catenin in the normal and malignant human endometrium: An inverse correlation between E-cadherin and nuclear β-catenin expression

Anticancer Research

Volumn 24, Issue 6, 2004, Pages 3843-3850

  Shih, Hsien Chang ^a   Shiozawa, Tanri ^a   Miyamoto, Tsutomu ^a   Kashima, Hiroyasu ^a   Feng, Yu Zhen ^a   Kurai, Miyuki ^a   Konishi, Ikuo ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

catenin; E cadherin; Endometrial carcinoma; Endometrium; Immunohistochemistry

Indexed keywords

BETA CATENIN; UVOMORULIN; CADHERIN; CTNNB1 PROTEIN, HUMAN; CYTOSKELETON PROTEIN; TRANSACTIVATOR PROTEIN;

ARTICLE; CANCER GRADING; CELL ADHESION; CELL NUCLEUS; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOPLASM; ENDOMETRIUM; ENDOMETRIUM CANCER; ENDOMETRIUM PROLIFERATIVE PHASE; ENDOMETRIUM SECRETORY PHASE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; BIOSYNTHESIS; CANCER STAGING; CELL MEMBRANE; COMPARATIVE STUDY; CYTOLOGY; ENDOMETRIOID CARCINOMA; ENDOMETRIUM TUMOR; METABOLISM; PATHOLOGY;

BETA CATENIN; CADHERINS; CARCINOMA, ENDOMETRIOID; CELL MEMBRANE; CELL NUCLEUS; CYTOPLASM; CYTOSKELETAL PROTEINS; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM STAGING; TRANS-ACTIVATORS;

EID: 14944385644     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Takeichi M: Cadherin cell adhesion receptors as a morphogenetic regulator. Science 251: 1451-5, 1991.
2. Alattia JR, Tong KI, Takeichi M and Ikura M: Cadherins. Methods Mol Biol 172: 199-210, 2002.
3. Pignatelli M and Vessey CJ: Adhesion molecules: novel molecular tools in tumor pathology. Hum Pathol 25: 849-56, 1994.
4. Kemler R: From cadherins to catenins: cytoplasmic protein interactions and regulation of cell adhesion. Trends Genet 9: 317-21, 1993.
5. Behrens J: Cadherins as determinants of tissue morphology and suppressors of invasion. Acta Anat (Basel) 149: 165-9, 1994.
6. Jiang WG: E-cadherin and its associated protein catenins, cancer invasion and metastasis. Br J Surg 83: 437-46, 1996.
7. Gumbiner BM: Cell adhesion: The molecular basis of tissue architecture and morphogenesis. Cell 84: 345-57, 1996.
8. Provost E and Rimm DL: Controversies at the cytoplasmic face of the cadherin-based adhesion complex. Curr Opin Cell Biol 11: 567-72, 1999.
9. Gumbiner BM: Signal transduction by β-catenin. Curr Opin Cell Biol 7: 634-40, 1995.
10. Barth AI, Nathke IS and Nelson WJ: Cadherins, catenins and APC protein: interplay between cytoskeletal complexes and signaling pathways. Curr Opin Cell Biol 19: 683-90, 1997.
11. Morin PJ: Beta-catenin signaling and cancer. Bioessays 21: 1021-30, 1999.
12. Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B et al: Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC. Science 275: 1787-90, 1997.
13. Sparks AB, Morin PJ, Vogelstein B and Kinzler KW: Mutational analysis of the APC/β-catenin/Tcf pathway in colorectal cancer. Cancer Res 8: 1130-34, 1998.
14. Molennar M, Wetering M, Oosterwegel M, Peterson-Madulo J, Goldsave S, Kornek V et al: XTcf-3 transcription factor mediates β-catenin-induced axis formation in xenopus embryos. Cell 86: 391-9, 1996.
15. Behrens J, von Kreis JP, Kuhl M, Bruhn L, Wedlich D, Grosschedl R et al: Functional interaction of β-catenin with the transcription factor LEF-1. Nature 382: 638-42, 1996.
16. Tetsu O and McCormick F: β-Catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398: 422-6, 1999.
17. Kim YT, Choi EK, Kim JW, Kim DK, Kim SH and Yang WI: Expression of E-cadherin and alpha-, beta-, gamma-catenin proteins in endometrial carcinoma. Yonsei Med J 43: 701-11, 2002.
18. Holcomb K, Delatorre R, Pedemonte B, McLeod C, Anderson L and Chambers J: E-cadherin expression in endometrioid, papillary serous, and clear cell carcinoma of the endometrium. Obstet Gynecol 100: 1290-5, 2002.
19. Saegusa M, Hashimura M, Yoshida T and Okayasu I: Beta-catenin mutations and aberrant nuclear expression during endometrial tumorigenesis. Br J Cancer 84: 209-17, 2001.
20. Fukuchi T, Sakamoto M, Tsuda H, Maruyama K, Nozawa S and Hirohashi S: Beta-catenin mutation in carcinoma of the uterine endometrium. Cancer Res 58: 3526-8, 1998.
21. Kobayashi K, Sagae S, Nishioka Y, Tokino T and Kudo R: Mutation of β-catenin gene in endometrial carcinomas. Jpn Cancer Res 90: 55-9, 1999.
22. Moreno-Bueno G, Hardisson D, Sanchez C, Sarrio D, Cassia R, Garcia-Rostan G et al: Abnormalities of the APC/beta-catenin pathway in endometrial cancer. Oncogene 21: 7981-90, 2002.
23. Shih HC, Shiozawa T, Miyamoto T, Uchikawa J, Feng Y, Kashima H et al: Nuclear localization of beta-catenin is correlated with the expression of cyclin D1 in endometrial carcinomas. Anticancer Res 23: 3749-54, 2003.
24. Noyes RW, Hertig AT and Rock J: Dating the endometrial biopsy. Fertil Steril 1: 3-25, 1950.
25. van der Linden PJ, de Goeij AF, Dunselman GA, Erkens HW and Evers JL: Expression of cadherins and integrins in human endometrium throughout the menstrual cycle. Fertil Steril 63: 1210-6, 1995.
26. Tabibzadeh S, Babaknia A, Kong QF, Zupi E, Marconi D, Romanini C et al: Menstruation is associated with disordered expression of desmoplakin I/II and cadherin/catenins and conversion of F- to G-actin in endometrial epithelium. Hum Reprod 10: 776-84, 1995.
27. Nei H, Saito T, Yamasaki H, Mizumoto H, Ito E and Kudo R: Nuclear localization of beta-catenin in normal and carcinogenic endometrium. Mol Carcinog 25: 207-18, 1999.
28. Winterhager E and Grummer R: Cell-cell communications in the endometrium. In: The Endometrium (Glsser SR, Aplin JD, Giudice LC, Tabibzadeh eds.), London, Taylor & Francis. 2002, pp46-56.
29. Wynn RM: Histology and ultrastructure of the human endometrium. In: Biology of the Uterus, 2nd ed. (Wynn RH ed), New York, Plenum Press. 1977, pp341-76.
30. Coutifaris C, Kao LC, Sehdev HM, Chin U, Babalola GO, Blaschuk OW et al: E-cadherin expression during the differentiation of human trophoblasts. Development 113: 767-77, 1991.
31. MacCalman CD, Furth EE, Omigbodun A, Bronner M, Coutifaris C and Strauss JF 3rd: Regulated expression of cadherin-11 in human epithelial cells: a role for cadherin-11 in trophoblast-endometrium interactions? Dev Dyn 206: 201-11, 1996.
32. Bui TD, Zhang L, Rees MC, Bicknell R and Harris AL: Expression and hormone regulation of Wnt 2, 3, 4, 5a, 7a, 7b and 10b in normal human endometrium and endometrial carcinoma. Br J Cancer 75: 1131-6, 1997.
33. Saegusa M, Hamano M, Kuwata T, Yoshida T, Hashimura M, Akino F et al: Up-regulation and nuclear localization of beta-catenin in endometrial carcinoma in response to progesterone therapy. Cancer Sci 94: 103-11, 2003.
34. Fujimoto J, Ichigo S, Hori M and Tamaya T: Expressions of E-cadherin and alpha- and beta-catenin mRNAs in uterine endometrial cancers. Eur J Gynaecol Oncol 19: 78-81, 1998.
35. Schlosshauer PW, Ellenson LH and Soslow RA: Beta-catenin and E-cadherin expression patterns in high-grade endometrial carcinoma are associated with histological subtype. Mod Pathol 15: 1032-7, 2002.
36. Saito T, Nishimura M, Yamasaki H and Kudo R: Hypermethylation in promoter region of E-cadherin gene is associated with tumor dedifferention and myometrial invasion in endometrial carcinoma. Cancer 97: 1002-9, 2003.
37. Berchuck A and Boyd J: Molecular basis of endometrial cancer. Cancer 76: 2034-40, 1995.